K231575 is an FDA 510(k) clearance for the Vecttor VT-300. Classified as Interferential Current Therapy (product code LIH), Class II - Special Controls.
Submitted by Artaflex, Inc. (Markham, CA). The FDA issued a Cleared decision on February 8, 2024 after a review of 253 days - an extended review cycle.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.
Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.
View all Artaflex, Inc. devices